000 | 03048nam a22005655i 4500 | ||
---|---|---|---|
999 |
_c200458314 _d76526 |
||
003 | DE-He213 | ||
005 | 20231109085906.0 | ||
007 | cr nn 008mamaa | ||
008 | 220207s2022 sz | s |||| 0|eng d | ||
020 | _a9783030943530 | ||
024 | 7 |
_a10.1007/978-3-030-94353-0 _2doi |
|
040 |
_aTR-AnTOB _beng _cTR-AnTOB _erda |
||
060 | _aQW 940 | ||
072 | 7 |
_aMQC _2bicssc |
|
072 | 7 |
_aMED058000 _2bisacsh |
|
072 | 7 |
_aMQC _2thema |
|
096 | _aQW940EBK | ||
245 | 1 | 4 |
_aThe EBMT/EHA CAR-T Cell Handbook _h[electronic resource] / _cedited by Nicolaus Kröger, John Gribben, Christian Chabannon, Ibrahim Yakoub-Agha, Hermann Einsele. |
250 | _a1st ed. 2022. | ||
264 | 1 |
_aCham : _bSpringer International Publishing : _bImprint: Springer, _c2022. |
|
300 | _a1 online resource | ||
336 |
_atext _btxt _2rdacontent |
||
337 |
_acomputer _bc _2rdamedia |
||
338 |
_aonline resource _bcr _2rdacarrier |
||
347 |
_atext file _bPDF _2rda |
||
505 | 0 | _a1. Introduction -- 2. The science behind CAR-T Cells -- 3. Manufacturing CAR-T Cells: the supply chain -- 4. Clinical indications for CAR-T Cells -- 5. Clinical management of patients treated with CAR-T Cells -- 6. Access to CAR-T cells. . | |
506 | 0 | _aOpen Access | |
520 | _aThis first open access European CAR-T Handbook, co-promoted by the European Society for Blood and Marrow Transplantation (EBMT) and the European Hematology Association (EHA), covers several aspects of CAR-T cell treatments, including the underlying biology, indications, management of side-effects, access and manufacturing issues. This book, written by leading experts in the field to enhance readers’ knowledge and practice skills, provides an unparalleled overview of the CAR-T cell technology and its application in clinical care, to enhance readers’ knowledge and practice skills. | ||
650 | 0 | _aNursing. | |
650 | 0 | _aInternal medicine. | |
650 | 0 | _aSurgery. | |
650 | 1 | 4 | _aNursing. |
650 | 2 | 4 | _aInternal Medicine. |
650 | 2 | 4 | _aSurgery. |
653 | 0 | _aImmunotherapy, Adoptive | |
653 | 0 | _aReceptors, Chimeric Antigen -- therapeutic use | |
700 | 1 |
_aKröger, Nicolaus. _eeditor. _0(orcid)0000-0001-5103-9966 _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
700 | 1 |
_aGribben, John. _eeditor. _0(orcid)0000-0002-8505-7430 _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
700 | 1 |
_aChabannon, Christian. _eeditor. _0(orcid)0000-0002-3755-4889 _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
700 | 1 |
_aYakoub-Agha, Ibrahim. _eeditor. _0(orcid)0000-0003-4524-8782 _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
700 | 1 |
_aEinsele, Hermann. _eeditor. _0(orcid)0000-0002-7680-0819 _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
710 | 2 | _aSpringerLink (Online service) | |
856 | 4 | 0 |
_uhttps://doi.org/10.1007/978-3-030-94353-0 _3Springer eBooks _zOnline access link to the resource |
942 |
_2NLM _cEBK |
||
041 | _aeng |